Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort

International Journal of Cancer

Volumn 137, Issue 8, 2015, Pages 1938-1946

  Murphy, Gwen ^a   Freedman, Neal D ^a   Michel, Angelika ^b   Fan, Jin Hu ^c   Taylor, Philip R ^a   Pawlita, Michael ^b   Qiao, You Lin ^c   Zhang, Han ^a   Yu, Kai ^a   Abnet, Christian C ^a   Dawsey, Sanford M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c CANCER HOSPITAL   (China)

Author keywords

esophageal cancer; gastric cancer; Helicobacter pylori; multiplex serology

Indexed keywords

BACTERIAL ANTIGEN; CAGA PROTEIN; CHAPERONIN 60; CONSERVED HYPOTHETICAL SECRETED PROTEIN; HP0305 PROTEIN; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VACUOLATING TOXIN;

ADULT; ARTICLE; CANCER RISK; CHINESE; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC NONCARDIA CANCER; HELICOBACTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX SEROLOGY ASSAY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; SEROPREVALENCE; STOMACH CANCER; ADENOCARCINOMA; AGED; BLOOD; CLINICAL TRIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNOLOGY; META ANALYSIS; MICROBIOLOGY; MIDDLE AGED; RISK FACTOR; STOMACH NEOPLASMS;

ADENOCARCINOMA; AGED; ANTIGENS, BACTERIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; STOMACH NEOPLASMS;

EID: 84939579291     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29543     Document Type: Article

References (29)

1. Uemura N, Okamoto S, Yamamoto S, et al., Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-89.
2. Kuipers EJ, Perez-Perez GI, Meuwissen SG, et al., Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995; 87: 1777-80.
3. Atherton JC, Cao P, Peek RM, Jr,., et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-7.
4. Kamangar F, Dawsey SM, Blaser MJ, et al., Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006; 98: 1445-52.
5. Haas G, Karaali G, Ebermayer K, et al., Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics 2002; 2: 313-24.
6. Krah A, Miehlke S, Pleissner KP, et al., Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma. Int J Cancer 2004; 108: 456-63.
7. Mini R, Bernardini G, Salzano AM, et al., Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 833: 63-79.
8. Gao L, Michel A, Weck MN, et al., Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res 2009; 69: 6164-70.
9. Gao L, Weck MN, Michel A, et al., Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology. Cancer Res 2009; 69: 2973-80.
10. Li B, Taylor PR, Li JY, et al., Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance. Ann Epidemiol 1993; 3: 577-85.
11. Blot WJ, Li JY, Taylor PR, et al., Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 85: 1483-92.
12. Tran GD, Sun XD, Abnet CC, et al., Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005; 113: 456-63.
13. Qiao YL, Dawsey SM, Kamangar F, et al., Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian general population nutrition intervention trial. J Natl Cancer Inst 2009; 101: 507-18.
14. Kamangar F, Qiao YL, Blaser MJ, et al., Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer 2007; 96: 172-6.
15. Lam TK, Freedman ND, Fan J-H, et al., Pre-diagnostic plasma vitamin C and risk of gastric adenocarcinoma and esophageal squamous cell carcinoma in the general population nutrition intervention trial. Am J Clin Nutr, 2013; 98: 1289-97.
16. Michel A, Waterboer T, Kist M, et al., Helicobacter pylori multiplex serology. Helicobacter 2009; 14: 525-35.
17. Waterboer T, Sehr P, Michael KM, et al., Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 2005; 51: 1845-53.
18. Murphy G, Michel A, Taylor PR, et al., Association of seropositivity to helicobacter species and biliary tract cancer in the ATBC study. Hepatology 2014; 60: 1963-71.
19. Limburg P, Qiao Y, Mark S, et al., Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst 2001; 93: 226-33.
20. Tibshirani R,. Regression shrinkage and selection via the lasso: a retrospective. J R Stat Soc: Ser B (Stat Methodol) 2011; 73: 273-82.
21. Blaser MJ, Falkow S,. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009; 7: 887-94.
22. Epplein M, Zheng W, Xiang YB, et al., Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers Prev 2012; 21: 2185-92.
23. Stein M, Rappuoli R, Covacci A,. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 2000; 97: 1263-8.
24. Hatakeyama M,. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004; 4: 688-94.
25. Nogueira C, Figueiredo C, Carneiro F, et al., Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 2001; 158: 647-54.
26. Vanet A, Labigne A,. Evidence for specific secretion rather than autolysis in the release of some Helicobacter pylori proteins. Infect Immun 1998; 66: 1023-7.
27. Bergonzelli GE, Granato D, Pridmore RD, et al., GroEL of lactobacillus johnsonii la1 (NCC 533) is cell surface associated: potential role in interactions with the host and the gastric pathogen Helicobacter pylori. Infect Immun 2006; 74: 425-34.
28. Deml L, Aigner M, Decker J, et al., Characterization of the Helicobacter pylori cysteine-rich protein a as a T-helper cell type 1 polarizing agent. Infect Immun 2005; 73: 4732-42.
29. Fischer W, Puls J, Buhrdorf R, et al., Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 2001; 42: 1337-48.